Using the functionally differentiated colonic cell line, HT29-19A, we have examined sites at which inhibitory G-proteins mediate the antisecretory actions of somatostatin (SST) and the a2-adrenergic agonist, clonidine (CLON) at the epithelial level. Both agents caused a dose-dependent inhibition (EC5:
cretion in the mammalian intestine (1) (2) (3) (4) . Both show promise as therapeutic agents in the treatment of secretory disorders (5) . The cellular sites of action of these agonists and/or the nature of their molecular interaction with the secretory process, however, remain poorly defined. Evidence that tetrodotoxin and other neuronal blockers can inhibit the actions of SST and a2-ADR in some species suggests that the enteric nervous system may be an important site of action (2, 6) . However, the identification of specific receptor sites for both types of agonist on enterocyte membranes (7, 8) implies a direct action mediated at the epithelial level.
In several systems SST and a2-ADR have been shown to mediate their cellular effects through the receptor activation of inhibitory G-proteins (Gi) coupled to the inhibition of adenylate cyclase (9, 10) and other membrane events including modulation of K+ and Ca2+ channels ( 1 1, 12 Recent studies using human colonic adenocarcinoma cell lines suggest that they may be useful models with which to address these questions. HT29 cells have been shown to express a2-ADR receptors coupled to the inhibition of adenylate cyclase (14, 15) and other mechanisms (16) though no attempt was made to investigate their linkage to ion transport processes. In the T84 cell line SST at high concentrations was reported to attenuate ion secretory responses ( 17) though the molecular mechanism of inhibition was not investigated.
In this study we have used the HT29-19A cell line, a differentiated subclone of HT29 that actively secretes Cl-in response to neurohumoral agonists ( 18) to examine in greater detail the effects of SST and CLON in a pure epithelium. Our data suggest that both agents can inhibit cAMP-and Ca2+/protein kinase C (PKC)-activated secretion, and that these effects are mediated by pertussis toxin (PT)-sensitive G-proteins directed at multiple sites along the secretory pathway located both proximal and distal to the generation of second messengers.
Methods
Cell culture. The HT29-19A colonic adenocarcinoma cell line was kindly supplied by Dr C. Laboisse, INSERM, Paris, and used between passages 38 and 52. Cells were grown in DME supplemented with 15 mM Hepes, 2 mM glutamine, 50 IU/ml penicillin, 50 Ag/ml streptomycin, and 10% fetal calf serum in a humidified atmosphere of 5% C02/95% air at 37°C.
guanine-nucleotide-binding protein; IBMX, 3-isobutyl-1-methylxanthine; IP3, inositol, 1,4,5-trisphosphate; Isc, short circuit current; PDB, 4a-phorbol, 12,13-dibutyrate; PKC, protein kinase C; PT, pertussis toxin; RT, transepithelial resistance; SST, somatostatin; THAP, thapsigargin.
Monolayers ofepithelial cells were formed on permeable filter supports. Cells were seeded at a density of 3 x 105/cm2 onto a collagencoated (rat tail; 2.5 mg/ml) filter (Millipore Corp., Bedford, MA) to which had been glued a silicone washer leaving a growing area of 1.13 cm2. After seeding, filters were initially floated on medium in petri dishes and were submerged after 18 h. Filters were used for transepithelial electrical studies 10-15 d after seeding. Under these conditions HT29-19A cells form a polarized epithelial monolayer (17) . Cells grown on similar permeable supports were also used for measurements of intracellular cAMP (Millipore Corp.) or intracellular free calcium,
[Ca]i (Nunc, Copenhagen, DK). Cellular levels of inositol 1,4,5-trisphosphate (OP3) were measured in cells grown to confluency in 22-mm plastic dishes.
Measurements of transepithelial electrical responses. Changes in short circuit current (Isc) were used as an indicator of electrogenic ion transport ( 18 MA/cm2 and a mean RT of 234±12.6 0/cm2 (n = 126). The Isc generated by these cells is assumed to be principally CP-based on the observations that Isc stimulated by the cAMP agonist forskolin was (a) abolished in Cl--free media, (b) inhibited over 80% by serosal application of 100 MM bumetanide, and (c) unaffected by apical application of 1 mM amiloride. In addition, a recent study has also shown that forskolin stimulates apical 'C1 efflux in this cell line (20).
Determination ofcellular cAMP. Cell monolayers grown on Millipore filters were rinsed several times with a Hepes-buffered Ringer's solution ( 15 mM, pH 7.5) and incubated in the same buffer with agonists for various times at 37°C. Where indicated the phosphodiesterase inhibitor 3-isobutyl-l-methylxanthine (IBMX; 0.25 mM) was included to minimize cAMP breakdown. Incubations were stopped by rapid washing in ice-cold Ringer's solution (< 5 s) and cellular cAMP extracted overnight at -70°C into ethanol/water (2:1). Extracts were dried under N2, reconstituted in Tris buffer (pH 7.5), and assayed for cAMP as previously described ( 19).
Determination ofcellular IP3 production. Cells were grown to confluency in 22-mm plastic dishes. After aspiration of the growth medium, cells were incubated in Hepes-Ringer's solution for 2 min at 37°C before addition of agonists. Incubations (0-5 min) were terminated by the addition ofice-cold perchloric acid (4% vol/vol) and kept on ice for 15 min. Samples of the perchloric acid extract were neutralized by addition of 5 M KOH and centrifuged at 12,000g for 5 min to remove KC104 precipitate. Aliquots of the supernatant were assayed for 1P3 using a binding protein isolated from bovine adrenal cortex as described by Palmer et al. (21 
Results
SSTand CLON inhibit cAMP-mediatedsecretion at sitesproximal and distal to cAMP production. The cAMP agonist PGE2 caused a rapid and sustained increase in Isc across HT29-19A monolayers compatible with a stimulation of Cl-secretion ( Fig. 1 A) . Application of SST (0.1 MuM) to the basolateral bathing medium at the peak of the secretory response induced a rapid inhibition of Isc by 60-70% within 3 min of addition. The inhibitory effects of SST on PGE2-stimulated secretion were dose dependent with a threshold at 1 nM and a half-maximal response (EC50) at 35 nM SST (Fig. 2 A) . CLON-induced Isc inhibition was also dose-dependent although in this case the EC50 was significantly higher at 225 nM ( Fig. 2 B) . In both cases the EC50 values obtained in HT29-19A cells are similar to those reported for inhibition of fluid and electrolyte secretion in whole intestine (6, 26, 27) .
The reversal of PGE2-induced secretion by SST and CLON in HT29-19A monolayers was associated with a marked inhibition of cAMP production (Fig. 2 ). While for SST there was a close correlation between inhibition of Isc and cAMP (EC50's 35 and 31 nM, respectively) there appeared to be some dissociation of these parameters using CLON. The half-maximal concentration ofCLON required to inhibit Isc (225 nM ) was significantly higher (P < 0.01) than that for cAMP (70 nM) though the maximum level of inhibition was similar in both cases (82% vs. 79%). These results suggest that attenuation of cAMP production is a significant component of the antisecretory effects of SST and CLON in HT29-19A cells.
The role of Gi-proteins in the reversal of PGE2-induced secretion by SST 1 ) and effectively reversed their inhibitory effects on stimulated cAMP accumulation (Fig. 3 ).
To confirm that PT was acting on Gi-like proteins in this system we examined the ability of PT to ADP-ribosylate substrates in membranes from HT29-19A cells (Fig. 4) band by PT in vitro (Fig. 4) , confirming that PT can modify G-proteins in intact HT29-19A cells.
The ability of SST to inhibit secretion caused by CT, which permanently activates G, (stimulatory guanine nucleotidebinding protein) resulting in a prolonged increase in cellular cAMP in intestinal cells, was also assessed. Table I shows that the rise in Isc stimulated by CT could be significantly inhibited by SST though inhibition was generally lower (45-50%) than that observed for the receptor agonist PGE2. These effects were also accompanied by a reduction in the ability of CT to raise cAMP levels though, interestingly, the level of inhibition of cAMP accumulation was greater (z 80%), suggesting that for CT there is a poorer correlation between Isc and cAMP than was observed for PGE2. The effects of SST appear to be largely independent of CT concentration with both supramaximal (2 Mg/ml) and ECm (0.002 ug/ml) doses Increasing evidence suggests that some ofthe cellular effects of agonists that activate Gi-proteins may be mediated at sites distal to second messenger production ( 1 1). We, therefore, examined the effects ofSST and CLON on the secretory response to the permeant cAMP analogue, db-cAMP. db-cAMP (200 ,gM) caused a sustained activation of Isc in HT29-19A cells (Fig. 5) . The addition of SST (1 gM) at the peak of this re- Though the kinetics of inhibition were similar to those observed with the receptor-mediated agonist, PGE2 comparison ofthe dose-response curves for SST inhibition ofthe two secretagogues (Fig. 6 ) showed interesting differences. First, unlike PGE2, the maximal inhibition of db-cAMP-stimulated secretion that could be achieved with SST was significantly lower (40% vs. 85%), even though concentrations of PGE2 and dbcAMP were chosen to produce similar increases in Isc (PGE2 (Fig. 7) . While SST was able to inhibit secretion induced by low concentrations (100 MM) of db-cAMP by up to 60% at higher concentrations (> 400 uM) inhibition was negligible.
These data suggest that the cAMP-activated secretory pathway in HT29-19A colonocytes has Gi-regulated sites located both proximal and distal to cAMP production which mediate the antisecretory actions of SST and CLON. Experiments were also conducted to examine the additivity of SST and CLON effects on db-cAMP-activated cells (Fig. 8 ). Separate addition of either agonist caused a 30-40% inhibition of Isc. However, when SST and CLON are added sequentially the inhibitory response to the second agonist is clearly attenuated producing a much less than additive response. Similar results were obtained when SST and CLON were added simultaneously. This may indicate that SST and a2-ADR receptors linked to the inhibition of secretion are coupled to a common pool of Gi-proteins.
Inhibition ofsecretion stimulated by Ca2"-mobilizing agonists. The Ca2+/PKC signaling system represents a second, discrete mechanism by which agonists can stimulate the Cl-secretory process in HT29-19A and other colonic cell lines (20, 29) . We therefore investigated the ability of antisecretory agonists to modulate secretion stimulated by this route. We initially examined the effects of SST and CLON on the Isc response to the muscarinic agonist, CCh. In this cell line CCh (200 AM) elicited a modest increase in Isc (6-7 ,A) compared to that seen with cAMP agonists. (Fig. 9 A) . Pretreatment with tion. In contrast, low concentrations of the PKC activator, PDB (20 nM), which has been shown to activate PKC in these cells (31 ) stimulated a larger increase in Isc (5.1±0. 4 ,uA/cm2 [n = 7 ]) similar to that produced by CCh though more prolonged (Fig. 12) . In this case the addition ofSST caused a rapid inhibition ofIsc by 31.5±2.5% (n = 5) within 2 min ofaddition to the basolateral surface. The simultaneous addition ofTHAP and PDB (Fig. 12) 
Discussion
The present studies show that the peptide, SST and the a2-ADR agonist, CLON can act directly on the HT29-19A colonic cell line to inhibit the Isc, presumably due to Cl-secretion, induced by both cAMP-and Ca2+-dependent agonists. This effect mimics their antisecretory effects in the whole intestine. These actions appear to be mediated at multiple sites along the secretory pathway involving inhibition of cAMP generation but also at sites activated by cAMP and PKC activators which lie distal to second messenger production. Inhibition ofIsc stimulated by all types of secretagogue could be effectively reversed by pretreating cells with PT at concentrations which cause the ADP-ribosylation of a 41-kD Gi-like protein in HT29-19A membranes.
Our studies suggest that the inhibition ofcAMP generation is an important mechanism by which SST and CLON attenuate Cl -secretion in these cells. Gi activation is commonly associated with an inhibition ofadenylate cyclase and the PT-sensitive attenuation of cAMP accumulation by SST and CLON in HT29-19A cells is similar to that observed in other cell types. Other antisecretory agonists have been shown to limit cAMP production in intestinal cells including neuropeptide Y (32) and adenosine agonists acting through A1 receptors (33) . While the involvement of Gi was not tested in these studies it seems likely that the ability to lower intestinal cAMP levels through a Gi-linked mechanism may be a common feature of many agonists that act to limit secretion. In these studies there was a close relationship between the ability of SST to inhibit cAMP production and to reverse the Cl -secretion induced by agonists which raise cellular cAMP, suggesting that this may be a primary site of action for this agent. In the case of CLON, however, there appeared to be some dissociation between inhibition of the two parameters. Several recent observations in other cells also suggest that the relationship between Gi-linked effects and the inhibition of cAMP may not be so clear-cut. In the shark rectal gland, adenosine agonists were able to inhibit completely forskolin-stimulated C1-secretion despite significantly elevated cAMP levels (33) . Similarly, in the T84 cell line, secretion induced by high concentrations of PGE2 could be maintained despite a marked inhibition of cAMP production (34 (27, 35, 36) though in this case the possibility remains that measurements ofwhole mucosal cAMP may mask changes in specific epithelial "pools" of cAMP.
There is considerable evidence from the present study, however, that while the ability to lower epithelial cAMP levels is a characteristic property of antisecretory agents, they also interact with the secretory pathway at additional G-protein-linked sites which bypass the adenylate cyclase system. First, SST and CLON were able to partially inhibit secretion induced by the permeant cAMP analogues, db-cAMP and 8-bromo cAMP-an effect that was also blocked by PT. Secondly, both agonists were also effective inhibitors of secretion induced by the receptor-mediated Ca2+ -mobilizing ago- After incubation for 0-120 s reactions were stopped by rapid aspiration and addition of ice-cold perchloric acid. Cellular 1P3 was extracted and assayed as described in Methods. Results are mean±SEM from five determinations. nist, CCh reducing its effects by 60-70%. This action, again reversed by PT, occurred without any apparent inhibition of either IP3 production or increases in cytosolic free calcium,
[Ca]i. Other studies with somatostatin in intestinal cells have also implied a site of action distal to the rise in [Ca] i though in neither case was the involvement ofG-proteins investigated. A preliminary study in chicken enterocytes showed that epinephrine had no effect on agonist-stimulated increases in [Ca]i despite being a potent inhibitor of Ca2" dependent secretion in the intact mucosa (37) while in T84 cells high concentrations of SST (10 ,uM) were shown to inhibit Cl secretion induced by a calcium ionophore ( 17) . In some tissues there is evidence that SST acting through Gi can modulate some aspects of the Ca2" signaling pathway including inhibition of Ca2" channel opening (38) 39) , suggesting that PKC-dependent processes play a significant role in activating the Cl-secretory process in these cells. The ability of SST to induce a rapid, although partial, inhibition of PDB-induced secretion while having no significant effect on that induced by THAP alone suggests that SST acts to inhibit Ca2+/PKC-dependent secretion at a PKC-activated site in these cells. The ability of SST to inhibit the actions of PDB coupled with its lack ofeffect on IP3 (and therefore by inference associated diacylglycerol production) suggests a site of action distal to the activation of PKC itself. The possibility that SST may influence diacylglycerol production generated from other sources such as the breakdown of phosphatidylcholine must also be considered (40) . The characteristics of inhibition observed using nonreceptor agonists to stimulate secretion were somewhat different from those seen with receptor mediated agonists. The secretion induced by nonreceptor agonists generally appeared to be more difficult to inhibit with both db-cAMP and PDB (25-50%) showing a lesser degree of inhibition than either PGE2 or CCh (60-80%). In addition, with db-cAMP, the maximum level of inhibition appeared to be critically dependent on the extent to which the Cl-secretory process had been stimulated. Thus, at concentrations of db-cAMP > 400 uM (Isc rise 40 MA) inhibition was negligible while the same concentration ofSST caused a 50% reduction in secretion induced by 100 zM db-cAMP (Isc rise 10 ,uA). One explanation for this may be that Gi-like proteins regulate a distal site or sites which become increasingly rate limiting at suboptimal stimulation of the secretory pathway. Similarly, agonists that bypass the normal second messenger synthesis/degradation processes may be inherently more difficult to inhibit. The relative sensitivity ofreceptor-mediated agonists to SST and CLON would presumably result from inhibition being mediated at both proximal and distal sites.
The shown to have a greater effect on basolateral K+ permeability than on apical Cl-channels (41) . In preliminary studies we have found that SST has no influence on CCh-stimulated 86Rb efflux in HT29-1 9A despite significantly inhibiting the CCh-induced rise in Isc (G. Warhurst, unpublished observations). It is interesting to speculate from the differential effect of SST on these components that at least one site lies in close proximity to the apical C1-channel. Receptors linked through Gi have been shown to couple to ion conductances in a variety of cell types (11, 38) and there is growing evidence that G-proteins play a role in regulating ion channels in intestinal epithelial cells. Recent studies have identified a G-protein activated C1-channel in the HT29-19A cell line (42) while G-proteins have also been implicated in the negative modulation of K+ conductances in guinea pig enterocytes (43) 
